ANIP
ANI Pharmaceuticals Inc
71.90$
+0.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.4% | 34.0% | 13.3% | 12.6% | 8.4% | 8.3% | 17.8% | 35.9% | 19.3% | 12.3% | 24.6% | 21.3% | 19.4% | |
| 11.5% | 11.5% | 10.7% | 10.6% | 10.6% | 11.9% | 11.6% | 11.0% | 9.9% | 9.2% | 8.8% | 7.4% | 8.8% | |
| 4.1% | 4.3% | 5.0% | 5.7% | 5.0% | 3.7% | 4.5% | 4.5% | 4.3% | 4.0% | 4.3% | 8.1% | 5.2% | |
| 4.2% | 21.1% | -7.4% | -3.3% | 5.6% | -2.5% | 0.7% | 17.1% | -7.8% | -10.9% | 0.2% | 2.4% | -3.9% | |
| 3.5% | 3.6% | 3.3% | 3.2% | 3.2% | 1.3% | 10.1% | 3.3% | 2.7% | 9.7% | 4.8% | 4.3% | 5.4% | |
| -3.5% | -3.6% | 6.5% | -3.2% | -268.7% | -5.6% | -10.1% | -3.3% | -2.7% | -0.6% | -4.8% | -1.1% | -2.2% | |
| 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -0.5% | -0.2% | -6.3% | -0.9% | -0.5% | -0.2% | -5.1% | -0.3% | -0.5% | -0.2% | -8.3% | -0.3% | -2.3% | |
| – | – | – | – | 235.1% | -1.1% | -1.0% | -1.0% | -0.9% | -1.6% | -1.7% | -1.5% | -1.5% | |
| 2.8% | -9.1% | -14.4% | -1.1% | 196.2% | -2.6% | -5.0% | -0.8% | 2.8% | -1.9% | -9.1% | -1.7% | -2.5% | |
| 23.8% | 21.3% | 5.4% | 8.3% | -64.1% | -0.1% | 2.5% | 32.2% | 19.7% | 9.3% | 10.8% | 18.4% | 14.6% | |
| 20.9% | 30.4% | 10.0% | 9.4% | 5.2% | 7.0% | 7.7% | 32.6% | 16.6% | 2.6% | 19.8% | 25.6% | 16.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.